Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
TIBD is a biotechnology company specializing in the design and engineering of novel biological systems and enzymes. Leveraging advanced synthetic biology and computational design, the company focuses on creating high-efficiency biocatalysts for both therapeutic and industrial applications. TIBD's core expertise lies in metabolic engineering and the development of microbial cell factories to produce high-value chemicals and pharmaceuticals. The company aims to bridge the gap between fundamental research in synthetic biology and commercial-scale production, providing innovative solutions for the life sciences and green manufacturing sectors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on TIBD.